skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 89  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: author/creator: Lexchin, Joel remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries
Material Type:
Article
Add to My Research

The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries

Global social policy, 2018-04, Vol.18 (1), p.7-27 [Peer Reviewed Journal]

The Author(s) 2017 ;ISSN: 1468-0181 ;EISSN: 1741-2803 ;DOI: 10.1177/1468018117734153

Digital Resources/Online E-Resources

2
Material Type:
Book
Add to My Research

Canada and Access to Medicines in Developing Countries: Intellectual Property Rights First

ISBN1-77125-092-5

Digital Resources/Online E-Resources

3
DRUG ECONOMICS IN DEVELOPING COUNTRIES
Material Type:
Article
Add to My Research

DRUG ECONOMICS IN DEVELOPING COUNTRIES

The Lancet (British edition), 1989-09, Vol.334 (8664), p.678-678 [Peer Reviewed Journal]

1989 ;Copyright Elsevier Limited Sep 16, 1989 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(89)90922-7 ;PMID: 2570925

Full text available

4
Medicine donations: a review of policies and practices
Material Type:
Article
Add to My Research

Medicine donations: a review of policies and practices

Globalization and health, 2023-09, Vol.19 (1), p.67-67, Article 67 [Peer Reviewed Journal]

2023. BioMed Central Ltd., part of Springer Nature. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1744-8603 ;EISSN: 1744-8603 ;DOI: 10.1186/s12992-023-00964-3 ;PMID: 37658389

Full text available

5
The pharmaceutical industry as a medicines provider
Material Type:
Article
Add to My Research

The pharmaceutical industry as a medicines provider

The Lancet (British edition), 2002-11, Vol.360 (9345), p.1590-1595 [Peer Reviewed Journal]

2002 Elsevier Ltd ;2003 INIST-CNRS ;Copyright Lancet Ltd. Nov 16, 2002 ;Copyright Elsevier Limited Nov 16, 2002 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(02)11527-3 ;PMID: 12443614 ;CODEN: LANCAO

Full text available

6
The Pharmaceutical Industry in Contemporary Capitalism
Material Type:
Article
Add to My Research

The Pharmaceutical Industry in Contemporary Capitalism

Monthly review (New York. 1949), 2018-03, Vol.69 (10), p.37-50 [Peer Reviewed Journal]

Copyright Monthly Review Press Mar 2018 ;ISSN: 0027-0520 ;EISSN: 0027-0520 ;DOI: 10.14452/MR-069-10-2018-03_3

Full text available

7
Economics and industry do not mean ethical conduct in clinical trials
Material Type:
Article
Add to My Research

Economics and industry do not mean ethical conduct in clinical trials

Journal of pharmaceutical policy and practice, 2013-12, Vol.6 (1), p.11-11, Article 11 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;Copyright © 2013 Lexchin; licensee BioMed Central Ltd. 2013 Lexchin; licensee BioMed Central Ltd. ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/2052-3211-6-11 ;PMID: 25848540

Full text available

8
Educating health professionals about drug and device promotion: a Nepalese perspective
Material Type:
Article
Add to My Research

Educating health professionals about drug and device promotion: a Nepalese perspective

PLoS medicine, 2007-02, Vol.4 (2), p.e89; author reply e88-e89; author reply e88 [Peer Reviewed Journal]

COPYRIGHT 2007 Public Library of Science ;COPYRIGHT 2007 Public Library of Science ;2007 P. Ravi Shankar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Shankar PR (2007) Educating Health Professionals about Drug and Device Promotion: A Nepalese Perspective. PLoS Med 4(2): e89. doi:10.1371/journal.pmed.0040089 ;2007 P. Ravi Shankar. 2007 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.0040089 ;PMID: 17326721

Full text available

9
Patent law
Material Type:
Article
Add to My Research

Patent law

The Lancet (British edition), 2003-03, Vol.361 (9362), p.1059-1059 [Peer Reviewed Journal]

2003 Elsevier Ltd ;Copyright National Library of Medicine - MEDLINE Abstracts Mar 22 2003 ;Copyright Elsevier Limited Mar 22, 2003 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(03)12810-3 ;PMID: 12660088 ;CODEN: LANCAO

Full text available

10
Intellectual property rights and drug prices
Material Type:
Article
Add to My Research

Intellectual property rights and drug prices

The Lancet (British edition), 1998-08, Vol.352 (9127), p.582-582 [Peer Reviewed Journal]

1998 Elsevier Ltd ;Copyright National Library of Medicine - MEDLINE Abstracts Aug 15 1998 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)79300-4 ;PMID: 9716098 ;CODEN: LANCAO

Full text available

11
Pharmaceutical Promotion in the Third World
Material Type:
Article
Add to My Research

Pharmaceutical Promotion in the Third World

Journal of drug issues, 1992-04, Vol.22 (2), p.417-453 [Peer Reviewed Journal]

1992 Florida State University College of Criminology and Criminal Justice ;Copyright Florida State University for and on behalf of The Florida State University Board of Trustees Spring 1992 ;ISSN: 0022-0426 ;EISSN: 1945-1369 ;DOI: 10.1177/002204269202200218 ;CODEN: JDGIA6

Full text available

12
One step forward, one step sideways? Expanding research capacity for neglected diseases
Material Type:
Article
Add to My Research

One step forward, one step sideways? Expanding research capacity for neglected diseases

BMC international health and human rights, 2010-07, Vol.10 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Lexchin; licensee BioMed Central Ltd. 2010 Lexchin; licensee BioMed Central Ltd. ;ISSN: 1472-698X ;EISSN: 1472-698X ;DOI: 10.1186/1472-698X-10-20 ;PMID: 20630063

Full text available

13
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
Material Type:
Article
Add to My Research

Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?

Healthcare policy, 2023-02, Vol.18 (3), p.17-24 [Peer Reviewed Journal]

Copyright © 2023 Longwoods Publishing ;Copyright Longwoods Publishing Corporation Feb 2023 ;Copyright © 2023 Longwoods Publishing 2023 Longwoods Publishing ;ISSN: 1715-6572 ;EISSN: 1715-6580 ;DOI: 10.12927/hcpol.2023.27038 ;PMID: 36917450

Full text available

14
Myths and Realities About Why Prescription Drug Prices in the United States Are So High
Material Type:
Article
Add to My Research

Myths and Realities About Why Prescription Drug Prices in the United States Are So High

Pharmaceutical medicine, 2017-06, Vol.31 (3), p.143-148 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2017 ;Copyright Springer Science & Business Media Jun 2017 ;ISSN: 1178-2595 ;EISSN: 1179-1993 ;DOI: 10.1007/s40290-017-0191-9

Full text available

15
Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews
Material Type:
Article
Add to My Research

Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews

BMC health services research, 2013-03, Vol.13 (1), p.88-88, Article 88 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;2013 Bishop and Lexchin; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2013 Bishop and Lexchin; licensee BioMed Central Ltd. 2013 Bishop and Lexchin; licensee BioMed Central Ltd. ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/1472-6963-13-88 ;PMID: 23497271

Full text available

16
Pharmaceutical research and development: what do we get for all that money?
Material Type:
Article
Add to My Research

Pharmaceutical research and development: what do we get for all that money?

BMJ (Online), 2012-08, Vol.345 (aug07 1), p.e4348-e4348 [Peer Reviewed Journal]

BMJ Publishing Group Ltd 2012 ;Copyright: 2012 © BMJ Publishing Group Ltd 2012 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.e4348 ;PMID: 22872694

Full text available

17
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
Material Type:
Article
Add to My Research

Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study

International journal of health policy and management, 2021-08, Vol.10 (8), p.495-499 [Peer Reviewed Journal]

2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;COPYRIGHT 2021 Kerman University of Medical Sciences ;2021 The Author(s); Published by Kerman University of Medical Sciences 2021 ;ISSN: 2322-5939 ;EISSN: 2322-5939 ;DOI: 10.34172/ijhpm.2020.100 ;PMID: 32610816

Full text available

18
From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development
Material Type:
Article
Add to My Research

From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development

Journal of evaluation in clinical practice, 2014-12, Vol.20 (6), p.809-812 [Peer Reviewed Journal]

2014 John Wiley & Sons, Ltd. ;ISSN: 1356-1294 ;EISSN: 1365-2753 ;DOI: 10.1111/jep.12244 ;PMID: 25327453

Full text available

19
Crisis at the pharmacy
Material Type:
magazinearticle
Add to My Research

Crisis at the pharmacy

CCPA monitor, 2018-03, Vol.24 (6), p.25

Copyright Canadian Centre for Policy Alternatives Mar/Apr 2018 ;ISSN: 1198-497X

Full text available

20
Foreign free riders and the high price of US medicines
Material Type:
Article
Add to My Research

Foreign free riders and the high price of US medicines

BMJ, 2005-10, Vol.331 (7522), p.958-960 [Peer Reviewed Journal]

2005 BMJ Publishing Group Ltd. ;Copyright 2005 BMJ Publishing Group Ltd ;Copyright: 2005 (c) 2005 BMJ Publishing Group Ltd. ;Copyright © 2005, BMJ Publishing Group Ltd. 2005 ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.331.7522.958 ;PMID: 16239695

Full text available

Results 1 - 20 of 89  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (78)

Refine My Results

Creation Date 

From To
  1. Before 2000  (7)
  2. 2000 To 2004  (13)
  3. 2005 To 2011  (14)
  4. 2012 To 2017  (24)
  5. After 2017  (33)
  6. More options open sub menu

Resource Type 

  1. Articles  (82)
  2. magazinearticle  (5)
  3. Books  (1)
  4. Book Chapters  (1)
  5. More options open sub menu

Language 

  1. Japanese  (2)
  2. French  (1)
  3. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Lexchin, Joel
  2. Lexchin, Joel

Searching Remote Databases, Please Wait